The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evolution and ecology of influenza A viruses
Webster, R. G., Bean, W. J., Gorman, O. T., Chambers, T. M., & Kawaoka, Y. (1992) · Microbiological Reviews · doi:10.1128/mr.56.1.152-179.1992 · Cited by 4,739
Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J., & Hendrickson, W. A. (1998) · Nature · doi:10.1038/31405 · Cited by 2,964
Self-citationReceptor Binding and Membrane Fusion in Virus Entry: The Influenza Hemagglutinin
Skehel, J. J., & Wiley, D. C. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.531 · Cited by 2,706
Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution
Wilson, I. A., Skehel, J. J., & Wiley, D. C. (1981) · Nature · doi:10.1038/289366a0 · Cited by 2,525
Antibody neutralization and escape by HIV-1
Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., et al. (2003) · Nature · doi:10.1038/nature01470 · Cited by 2,421
Mapping the Antigenic and Genetic Evolution of Influenza Virus
Smith, D. J., Lapedes, A. S., de Jong, J. C., Bestebroer, T. M., Rimmelzwaan, G. F., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2004) · Science · doi:10.1126/science.1097211 · Cited by 1,868
Self-citationWiley, D. C., Wilson, I. A., & Skehel, J. J. (1981) · Nature · doi:10.1038/289373a0 · Cited by 1,615
The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens
Wyatt, R., & Sodroski, J. (1998) · Science · doi:10.1126/science.280.5371.1884 · Cited by 1,598
Self-citationFouchier, R. A. M., Munster, V., Wallensten, A., Bestebroer, T. M., Herfst, S., Smith, D., Rimmelzwaan, G. F., Olsen, B., & Osterhaus, A. D. M. E. (2005) · Journal of Virology · doi:10.1128/jvi.79.5.2814-2822.2005 · Cited by 1,563
Self-citationHuman influenza A H5N1 virus related to a highly pathogenic avian influenza virus
Claas, E. C., Osterhaus, A. D., van Beek, R., De Jong, J. C., Rimmelzwaan, G. F., Senne, D. A., Krauss, S., Shortridge, K. F., & Webster, R. G. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11212-0 · Cited by 1,429
THE STRUCTURE AND FUNCTION OF THE HEMAGGLUTININ MEMBRANE GLYCOPROTEIN OF INFLUENZA VIRUS
Wiley, D. C., & Skehel, J. J. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.002053 · Cited by 1,415
Subbarao, K., Klimov, A., Katz, J., Regnery, H., Lim, W., Hall, H., Perdue, M., Swayne, D., Bender, C., Huang, J., et al. (1998) · Science · doi:10.1126/science.279.5349.393 · Cited by 1,362
The antigenic structure of the HIV gp120 envelope glycoprotein
Wyatt, R., Kwong, P. D., Desjardins, E., Sweet, R. W., Robinson, J., Hendrickson, W. A., & Sodroski, J. G. (1998) · Nature · doi:10.1038/31514 · Cited by 1,203
Self-citationTrkola, A., Purtscher, M., Muster, T., Ballaun, C., Buchacher, A., Sullivan, N., Srinivasan, K., Sodroski, J., Moore, J. P., & Katinger, H. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.1100-1108.1996 · Cited by 1,114
Self-citationEfficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody
Burton, D. R., Pyati, J., Koduri, R., Sharp, S. J., Thornton, G. B., Parren, P. W. H. I., Sawyer, L. S. W., Hendry, R. M., Dunlop, N., Nara, P. L., et al. (1994) · Science · doi:10.1126/science.7973652 · Cited by 1,100
Self-citationLi, M., Gao, F., Mascola, J. R., Stamatatos, L., Polonis, V. R., Koutsoukos, M., Voss, G., Goepfert, P., Gilbert, P., Greene, K. M., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10108-10125.2005 · Cited by 1,070
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
Muster, T., Steindl, F., Purtscher, M., Trkola, A., Klima, A., Himmler, G., Rüker, F., & Katinger, H. (1993) · Journal of Virology · doi:10.1128/jvi.67.11.6642-6647.1993 · Cited by 1,004
Leonard, C. K., Spellman, M. W., Riddle, L., Harris, R. J., Thomas, J. N., & Gregory, T. J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)86956-3 · Cited by 985
Rogers, G. N., & Paulson, J. C. (1983) · Virology · doi:10.1016/0042-6822(83)90150-2 · Cited by 941
Kwong, P. D., Doyle, M. L., Casper, D. J., Cicala, C., Leavitt, S. A., Majeed, S., Steenbeke, T. D., Venturi, M., Chaiken, I., Fung, M., et al. (2002) · Nature · doi:10.1038/nature01188 · Cited by 889
Self-citationActivation of influenza A viruses by trypsin treatment
Klenk, H.-D., Rott, R., Orlich, M., & Blödorn, J. (1975) · Virology · doi:10.1016/0042-6822(75)90284-6 · Cited by 843
Avian Influenza A (H5N1) in 10 Patients in Vietnam
Hien, T. T., Liem, N. T., Dung, N. T., San, L. T., Mai, P. P., Chau, N. V. V., Suu, P. T., Dong, V. C., Mai, L. T. Q., Thi, N. T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040419 · Cited by 839
Zwick, M. B., Labrijn, A. F., Wang, M., Spenlehauer, C., Saphire, E. O., Binley, J. M., Moore, J. P., Stiegler, G., Katinger, H., Burton, D. R., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10892-10905.2001 · Cited by 797
Self-citationAntibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition
Calarese, D. A., Scanlan, C. N., Zwick, M. B., Deechongkit, S., Mimura, Y., Kunert, R., Zhu, P., Wormald, M. R., Stanfield, R. L., Roux, K. H., et al. (2003) · Science · doi:10.1126/science.1083182 · Cited by 781
Self-citationDistribution and three-dimensional structure of AIDS virus envelope spikes
Zhu, P., Liu, J., Bess, J., Chertova, E., Lifson, J. D., Grisé, H., Ofek, G. A., Taylor, K. A., & Roux, K. H. (2006) · Nature · doi:10.1038/nature04817 · Cited by 780
Structural definition of a conserved neutralization epitope on HIV-1 gp120
Zhou, T., Xu, L., Dey, B., Hessell, A. J., Van Ryk, D., Xiang, S.-H., Yang, X., Zhang, M.-Y., Zwick, M. B., Arthos, J., et al. (2007) · Nature · doi:10.1038/nature05580 · Cited by 770
Self-citationHIV vaccine design and the neutralizing antibody problem
Burton, D. R., Desrosiers, R. C., Doms, R. W., Koff, W. C., Kwong, P. D., Moore, J. P., Nabel, G. J., Sodroski, J., Wilson, I. A., & Wyatt, R. T. (2004) · Nature Immunology · doi:10.1038/ni0304-233 · Cited by 765
Self-citationStructure of a V3-Containing HIV-1 gp120 Core
Huang, C.-C., Tang, M., Zhang, M.-Y., Majeed, S., Montabana, E., Stanfield, R. L., Dimitrov, D. S., Korber, B., Sodroski, J., Wilson, I. A., et al. (2005) · Science · doi:10.1126/science.1118398 · Cited by 731
Self-citationIscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses
Morein, B., Sundquist, B., Höglund, S., Dalsgaard, K., & Osterhaus, A. (1984) · Nature · doi:10.1038/308457a0 · Cited by 708
Binley, J. M., Wrin, T., Korber, B., Zwick, M. B., Wang, M., Chappey, C., Stiegler, G., Kunert, R., Zolla-Pazner, S., Katinger, H., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.13232-13252.2004 · Cited by 705
Self-citationLazarowitz, S. G., & Choppin, P. W. (1975) · Virology · doi:10.1016/0042-6822(75)90285-8 · Cited by 602
Structural Basis Of Immune Recognition Of Influenza Virus Hemagglutinin
Wilson, I. (1990) · Annual Review of Immunology · doi:10.1146/annurev.immunol.8.1.737 · Cited by 579
Adjuvants for human vaccines—current status, problems and future prospects
Gupta, R. K., & Siber, G. R. (1995) · Vaccine · doi:10.1016/0264-410x(95)00011-o · Cited by 551
Fatal Avian Influenza A (H5N1) in a Child Presenting with Diarrhea Followed by Coma
de Jong, M. D., Cam, B. V., Qui, P. T., Hien, V. M., Thanh, T. T., Hue, N. B., Beld, M., Phuong, L. T., Khanh, T. H., Chau, N. V. V., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044307 · Cited by 530
Influenza virus pleiomorphy characterized by cryoelectron tomography
Harris, A., Cardone, G., Winkler, D. C., Heymann, J. B., Brecher, M., White, J. M., & Steven, A. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607614103 · Cited by 529
Structure of an unliganded simian immunodeficiency virus gp120 core
Chen, B., Vogan, E. M., Gong, H., Skehel, J. J., Wiley, D. C., & Harrison, S. C. (2005) · Nature · doi:10.1038/nature03327 · Cited by 520
Weiner, G. J., Liu, H.-M., Wooldridge, J. E., Dahle, C. E., & Krieg, A. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10833 · Cited by 519
Stiegler, G., Kunert, R., Purtscher, M., Wolbank, S., Voglauer, R., Steindl, F., & Katinger, H. (2001) · AIDS Research and Human Retroviruses · doi:10.1089/08892220152741450 · Cited by 517
Leroux-Roels, I., Borkowski, A., Vanwolleghem, T., Dramé, M., Clement, F., Hons, E., Devaster, J.-M., & Leroux-Roels, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61297-5 · Cited by 498
GIANNINI, S., HANON, E., MORIS, P., VANMECHELEN, M., MOREL, S., DESSY, F., FOURNEAU, M., COLAU, B., SUZICH, J., & LOSONKSY, G. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.005 · Cited by 496
Ofek, G., Tang, M., Sambor, A., Katinger, H., Mascola, J. R., Wyatt, R., & Kwong, P. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.19.10724-10737.2004 · Cited by 490
Self-citationOkuno, Y., Isegawa, Y., Sasao, F., & Ueda, S. (1993) · Journal of Virology · doi:10.1128/jvi.67.5.2552-2558.1993 · Cited by 489
Mannose Receptor-Mediated Regulation of Serum Glycoprotein Homeostasis
Lee, S. J., Evers, S., Roeder, D., Parlow, A. F., Risteli, J., Risteli, L., Lee, Y. C., Feizi, T., Langen, H., & Nussenzweig, M. C. (2002) · Science · doi:10.1126/science.1069540 · Cited by 484
Zhang, M. (2004) · Glycobiology · doi:10.1093/glycob/cwh106 · Cited by 483
Cardoso, R. M. F., Zwick, M. B., Stanfield, R. L., Kunert, R., Binley, J. M., Katinger, H., Burton, D. R., & Wilson, I. A. (2005) · Immunity · doi:10.1016/j.immuni.2004.12.011 · Cited by 449
Self-citationGP120: Target for Neutralizing HIV-1 Antibodies
Pantophlet, R., & Burton, D. R. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090557 · Cited by 445
Self-citationPantaleo, G., & Koup, R. A. (2004) · Nature Medicine · doi:10.1038/nm0804-806 · Cited by 444
Salzwedel, K., West, J. T., & Hunter, E. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.2469-2480.1999 · Cited by 422
Energetics of the HIV gp120-CD4 binding reaction
Myszka, D. G., Sweet, R. W., Hensley, P., Brigham-Burke, M., Kwong, P. D., Hendrickson, W. A., Wyatt, R., Sodroski, J., & Doyle, M. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.9026 · Cited by 422
Self-citationOlshevsky, U., Helseth, E., Furman, C., Li, J., Haseltine, W., & Sodroski, J. (1990) · Journal of Virology · doi:10.1128/jvi.64.12.5701-5707.1990 · Cited by 405
Self-citationBroad HIV-1 neutralization mediated by CD4-binding site antibodies
Li, Y., Migueles, S. A., Welcher, B., Svehla, K., Phogat, A., Louder, M. K., Wu, X., Shaw, G. M., Connors, M., Wyatt, R. T., et al. (2007) · Nature Medicine · doi:10.1038/nm1624 · Cited by 383
Self-citationLi, M., Salazar-Gonzalez, J. F., Derdeyn, C. A., Morris, L., Williamson, C., Robinson, J. E., Decker, J. M., Li, Y., Salazar, M. G., Polonis, V. R., et al. (2006) · Journal of Virology · doi:10.1128/jvi.01730-06 · Cited by 359
Labrijn, A. F., Poignard, P., Raja, A., Zwick, M. B., Delgado, K., Franti, M., Binley, J., Vivona, V., Grundner, C., Huang, C.-C., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10557-10565.2003 · Cited by 357
Self-citationInfluenza and the challenge for immunology
Doherty, P. C., Turner, S. J., Webby, R. G., & Thomas, P. G. (2006) · Nature Immunology · doi:10.1038/ni1343 · Cited by 356
Broadly Neutralizing Antibodies Elicited by the Hypervariable Neutralizing Determinant of HIV-1
Javaherian, K., Langlois, A. J., LaRosa, G. J., Profy, A. T., Bolognesi, D. P., Herlihy, W. C., Putney, S. D., & Matthews, T. J. (1990) · Science · doi:10.1126/science.1703322 · Cited by 353
Frost, S. D. W., Wrin, T., Smith, D. M., Pond, S. L. K., Liu, Y., Paxinos, E., Chappey, C., Galovich, J., Beauchaine, J., Petropoulos, C. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504658102 · Cited by 353
Sauter, N. K., Hanson, J. E., Glick, G. D., Brown, J. H., Crowther, R. L., Park, S. J., Skehel, J. J., & Wiley, D. C. (1992) · Biochemistry · doi:10.1021/bi00155a013 · Cited by 343
Skeiky, Y. A. W., Alderson, M. R., Ovendale, P. J., Guderian, J. A., Brandt, L., Dillon, D. C., Campos-Neto, A., Lobet, Y., Dalemans, W., Orme, I. M., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7618 · Cited by 313
Receptor binding properties of human and animal H1 influenza virus isolates
Rogers, G. N., & D'Souza, B. L. (1989) · Virology · doi:10.1016/0042-6822(89)90249-3 · Cited by 313
Sagar, M., Wu, X., Lee, S., & Overbaugh, J. (2006) · Journal of Virology · doi:10.1128/jvi.00141-06 · Cited by 308
Antibody vs. HIV in a clash of evolutionary titans
Burton, D. R., Stanfield, R. L., & Wilson, I. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505126102 · Cited by 299
Self-citationMF59 Design and Evaluation of a Safe and Potent Adjuvant for Human Vaccines
Ott, G., Barchfeld, G. L., Chernoff, D., Radhakrishnan, R., van Hoogevest, P., & Van Nest, G. (1995) · Pharmaceutical Biotechnology · doi:10.1007/978-1-4615-1823-5_10 · Cited by 298
Matrix Protein 2 Vaccination and Protection against Influenza Viruses, Including Subtype H5N1
Tompkins, S. M., Zhao, Z.-S., Lo, C.-Y., Misplon, J. A., Liu, T., Ye, Z., Hogan, R. J., Wu, Z., Benton, K. A., Tumpey, T. M., et al. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1303.061125 · Cited by 297
Sandbulte, M. R., Jimenez, G. S., Boon, A. C. M., Smith, L. R., Treanor, J. J., & Webby, R. J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040059 · Cited by 295
Antigenic conservation and immunogenicity of the HIV coreceptor binding site
Decker, J. M., Bibollet-Ruche, F., Wei, X., Wang, S., Levy, D. N., Wang, W., Delaporte, E., Peeters, M., Derdeyn, C. A., Allen, S., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042510 · Cited by 295
Hartley, O., Klasse, P. J., Sattentau, Q. J., & Moore, J. P. (2005) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2005.21.171 · Cited by 290
Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein
Epstein, S. L., Kong, W.-P., Misplon, J. A., Lo, C.-Y., Tumpey, T. M., Xu, L., & Nabel, G. J. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.04.047 · Cited by 285
Wille-Reece, U., Flynn, B. J., Loré, K., Koup, R. A., Miles, A. P., Saul, A., Kedl, R. M., Mattapallil, J. J., Weiss, W. R., Roederer, M., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052433 · Cited by 275
Gao, W., Soloff, A. C., Lu, X., Montecalvo, A., Nguyen, D. C., Matsuoka, Y., Robbins, P. D., Swayne, D. E., Donis, R. O., Katz, J. M., et al. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.1959-1964.2006 · Cited by 270
Kwong, P. D., Wyatt, R., Sattentau, Q. J., Sodroski, J., & Hendrickson, W. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.4.1961-1972.2000 · Cited by 263
Self-citationScientific barriers to developing vaccines against avian influenza viruses
Subbarao, K., & Joseph, T. (2007) · Nature Reviews Immunology · doi:10.1038/nri2054 · Cited by 255
Exploiting the defensive sugars of HIV-1 for drug and vaccine design
Scanlan, C. N., Offer, J., Zitzmann, N., & Dwek, R. A. (2007) · Nature · doi:10.1038/nature05818 · Cited by 250
Immunologic correlates of protection induced by vaccination
PLOTKIN, S. A. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200101000-00013 · Cited by 242
Structure of influenza virus haemagglutinin complexed with a neutralizing antibody
Bizebard, T., Gigant, B., Rigolet, P., Rasmussen, B., Diat, O., Böseckei, P., Wharton, S. A., Skehel, J. J., & Knossow, M. (1995) · Nature · doi:10.1038/376092a0 · Cited by 238
Beyer, W. E. P., Palache, A. M., de Jong, J. C., & Osterhaus, A. D. M. E. (2002) · Vaccine · doi:10.1016/s0264-410x(01)00471-6 · Cited by 233
Thali, M., Olshevsky, U., Furman, C., Gabuzda, D., Posner, M., & Sodroski, J. (1991) · Journal of Virology · doi:10.1128/jvi.65.11.6188-6193.1991 · Cited by 222
Self-citationEisen, M. B., Sabesan, S., Skehel, J. J., & Wiley, D. C. (1997) · Virology · doi:10.1006/viro.1997.8526 · Cited by 204
CpG Oligodeoxynucleotides as Vaccine Adjuvants in Primates
Verthelyi, D., Kenney, R. T., Seder, R. A., Gam, A. A., Friedag, B., & Klinman, D. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1659 · Cited by 199
Hoelscher, M. A., Garg, S., Bangari, D. S., Belser, J. A., Lu, X., Stephenson, I., Bright, R. A., Katz, J. M., Mittal, S. K., & Sambhara, S. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68076-8 · Cited by 189
Wille-Reece, U., Wu, C.-Y., Flynn, B. J., Kedl, R. M., & Seder, R. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7676 · Cited by 185
Viral Persistence: HIV's Strategies of Immune System Evasion
Johnson, W. E., & Desrosiers, R. C. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104053 · Cited by 183
Glycoconjugate glycans as viral receptors
Olofsson, S., & Bergström, T. (2005) · Annals of Medicine · doi:10.1080/07853890510007340 · Cited by 181
Xiang, S.-H., Kwong, P. D., Gupta, R., Rizzuto, C. D., Casper, D. J., Wyatt, R., Wang, L., Hendrickson, W. A., Doyle, M. L., & Sodroski, J. (2002) · Journal of Virology · doi:10.1128/jvi.76.19.9888-9899.2002 · Cited by 178
Self-citationGorny, M. K., Williams, C., Volsky, B., Revesz, K., Cohen, S., Polonis, V. R., Honnen, W. J., Kayman, S. C., Krachmarov, C., Pinter, A., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.18.9035-9045.2002 · Cited by 177
Stoichiometry of Envelope Glycoprotein Trimers in the Entry of Human Immunodeficiency Virus Type 1
Yang, X., Kurteva, S., Ren, X., Lee, S., & Sodroski, J. (2005) · Journal of Virology · doi:10.1128/jvi.79.19.12132-12147.2005 · Cited by 169
Self-citationN-Linked Glycosylation Attenuates H3N2 Influenza Viruses
Vigerust, D. J., Ulett, K. B., Boyd, K. L., Madsen, J., Hawgood, S., & McCullers, J. A. (2007) · Journal of Virology · doi:10.1128/jvi.00769-07 · Cited by 167
Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates
Haynes, B. F., & Montefiori, D. C. (2006) · Expert Review of Vaccines · doi:10.1586/14760584.5.3.347 · Cited by 155
The Rational Design of an AIDS Vaccine
Douek, D. C., Kwong, P. D., & Nabel, G. J. (2006) · Cell · doi:10.1016/j.cell.2006.02.005 · Cited by 155
Fleury, D., Barrere, B., Bizebard, T., Daniels, R. S., Skehel, J. J., & Knossow, M. (1999) · Nature Structural Biology · doi:10.1038/9299 · Cited by 154
Development of Effective Vaccines against Pandemic Influenza
Subbarao, K., Murphy, B. R., & Fauci, A. S. (2006) · Immunity · doi:10.1016/j.immuni.2005.12.005 · Cited by 153
An Antibody That Prevents the Hemagglutinin Low pH Fusogenic Transition
Barbey-Martin, C., Gigant, B., Bizebard, T., Calder, L. J., Wharton, S. A., Skehel, J. J., & Knossow, M. (2002) · Virology · doi:10.1006/viro.2001.1320 · Cited by 143
Mechanism of Neutralization of Influenza Virus Infectivity by Antibodies
Knossow, M., Gaudier, M., Douglas, A. R., Barrere, B., Bizebard, T., Barbey, C., Gigant, B., & Skehel, J. J. (2002) · Virology · doi:10.1006/viro.2002.1625 · Cited by 138
Brunel, F. M., Zwick, M. B., Cardoso, R. M. F., Nelson, J. D., Wilson, I. A., Burton, D. R., & Dawson, P. E. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.1680-1687.2006 · Cited by 137
Self-citationGovorkova, E. A., Webby, R. J., Humberd, J., Seiler, J. P., & Webster, R. G. (2006) · The Journal of Infectious Diseases · doi:10.1086/505225 · Cited by 136
GARDASIL®: Prophylactic Human Papillomavirus Vaccine Development – From Bench Top to Bed-side
Shi, L., Sings, H. L., Bryan, J. T., Wang, B., Wang, Y., Mach, H., Kosinski, M., Washabaugh, M. W., Sitrin, R. D., & Barr, E. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100055 · Cited by 135
Virus-like particles as HIV-1 vaccines
Doan, L. X., Li, M., Chen, C., & Yao, Q. C. (2004) · Reviews in Medical Virology · doi:10.1002/rmv.449 · Cited by 116
FOUTS, T. R., Tuskan, R. G., Godfrey, K., Reitz, M. S., Hone, D. M., Lewis, G. K., & DeVico, A. L. (2000) · Journal of Virology · doi:10.1128/jvi.74.24.11427-11436.2000 · Cited by 115
ISCOMATRIX™ adjuvant for prophylactic and therapeutic vaccines
Drane, D. P., Gittleson, C., Boyle, J., & Maraskovsky, E. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.5.761 · Cited by 114
Crystal structures of influenza virus hemagglutinin in complex with high-affinity receptor
Watowich, S. J., Skehel, J. J., & Wiley, D. C. (1994) · Structure · doi:10.1016/s0969-2126(00)00073-3 · Cited by 111
FOUTS, T. R., Godfrey, K., Bobb, K., Montefiori, D. C., Hanson, C. V., Kalyanaraman, V. S., DeVico, A. L., & Pal, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412199 · Cited by 110
Longini, I. M., Halloran, M. E., Nizam, A., Wolff, M., Mendelman, P. M., Fast, P., & Belshe, R. B. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00419-3 · Cited by 109
Dey, B., Pancera, M., Svehla, K., Shu, Y., Xiang, S.-H., Vainshtein, J. M., Li, Y., Sodroski, J., Kwong, P. D., Mascola, J. R., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02500-06 · Cited by 105
Self-citationMcGaughey, G. B., Citron, M. P., Danzeisen, R. C., Freidinger, R. M., Garsky, V. M., Hurni, W. M., Joyce, J. G., Liang, X., Miller, M. D., Shiver, J. W., et al. (2003) · Biochemistry · doi:10.1021/bi026952u · Cited by 103
Mendelman, P. M., Cordova, J. M., & Cho, I. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00449-7 · Cited by 98
Edelman, R. (2003) · Expert Review of Vaccines · doi:10.1586/14760584.2.2.167 · Cited by 92
Change in tropism upon immune escape by human immunodeficiency virus
McKnight, Á., Weiss, R. A., Shotton, C. F., Takeuchi, Y., Hoshino, H., & Clapham, P. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.5.3167-3170.1995 · Cited by 85
Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination
Kong, W., Hood, C. L., Yang, Z., Wei, C., Xu, L., García‐Sastre, A., Tumpey, T. M., & Nabel, G. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607564103 · Cited by 81
Further Studies on the Activation of Influenza Virus by Proteolytic Cleavage of the Haemagglutinin
Klenk, H. D., Rott, R., & Orlich, M. (1977) · Journal of General Virology · doi:10.1099/0022-1317-36-1-151 · Cited by 77
de Wit, E., Munster, V. J., Spronken, M. I. J., Bestebroer, T. M., Baas, C., BEYER, W. E. P., Rimmelzwaan, G. F., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2005) · Journal of Virology · doi:10.1128/jvi.79.19.12401-12407.2005 · Cited by 73
Self-citationExtensively cross-reactive anti-HIV-1 neutralizing antibodies induced by gp140 immunization
Zhang, P. F., Cham, F., Dong, M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608635104 · Cited by 68
Predicting the Impact of a Nonsterilizing Vaccine against Human Immunodeficiency Virus
Davenport, M. P., Ribeiro, R. M., Chao, D. L., & Perelson, A. S. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.11340-11351.2004 · Cited by 66
McCormack, S., Tilzey, A., Carmichael, A. J., Gotch, F., Kepple, J., Newberry, A. M., Jones, G. J., Lister, S. G., Beddows, S. A., CHEINGSONG-POPOV, R., et al. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00388-6 · Cited by 58
Role of Neutralizing Antibodies in Protective Immunity Against HIV
Srivastava, I. K., Ulmer, J. B., & Barnett, S. W. (2005) · Human Vaccines · doi:10.4161/hv.1.2.1764 · Cited by 51
Combination DNA plus protein HIV vaccines
Lu, S. (2006) · Springer Seminars in Immunopathology · doi:10.1007/s00281-006-0028-1 · Cited by 45
Sagar, M., Kirkegaard, E., Lavreys, L., & Overbaugh, J. M. (2006) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.22.430 · Cited by 27
Cited by
Broad neutralization coverage of HIV by multiple highly potent antibodies
Walker, L. M., Huber, M., Doores, K. J., Falkowska, E., Pejchal, R., Julien, J.-P., Wang, S.-K., Ramos, A., Chan-Hui, P.-Y., Moyle, M., et al. (2011) · Nature · doi:10.1038/nature10373 · Cited by 1,480
Self-citationBroad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
Scheid, J. F., Mouquet, H., Feldhahn, N., Seaman, M. S., Velinzon, K., Pietzsch, J., Ott, R. G., Anthony, R. M., Zebroski, H., Hurley, A., et al. (2009) · Nature · doi:10.1038/nature07930 · Cited by 867
Self-citationCrawford, K. H. D., Eguia, R., Dingens, A. S., Loes, A. N., Malone, K. D., Wolf, C. R., Chu, H. Y., Tortorici, M. A., Veesler, D., Murphy, M., et al. (2020) · Viruses · doi:10.3390/v12050513 · Cited by 776
B cells in HIV infection and disease
Moir, S., & Fauci, A. S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2524 · Cited by 702
Complex-type N -glycan recognition by potent broadly neutralizing HIV antibodies
Mouquet, H., Scharf, L., Euler, Z., Liu, Y., Eden, C., Scheid, J. F., Halper-Stromberg, A., Gnanapragasam, P. N. P., Spencer, D. I. R., Seaman, M. S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217207109 · Cited by 550
Metadata
- Authors
- Karlsson Hedestam, G. B., Fouchier, R. A. M., Phogat, S., Burton, D. R., Sodroski, J., & Wyatt, R. T.
- Venue
- Nature Reviews Microbiology
- Published
- 2008-02
- Volume
- 6
- Issue
- 2
- Pages
- 143-155
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W2067107443
- Cited by
- 339
- References
- 115
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.